This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Folkman, J. Tumor Angiogenesis: Therapeutic Implications. New Eng. J. Med. 285, 1182–1186(1971).
Tuder, R.M., Flook, R.E. & Voelkel, N.F. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. J. Clin. Invest. 95, 1798–1807 (1995).
Banai, S. et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183–2189(1994).
Bauters, C., et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21, 314–325 (1995).
Takeshita, S. et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 90, 228–234 (1994).
Henry, T.D. et al. Results of intracoronary recombinant human vascular endothelial growth factor administration trial. J. Am. Coll. Card. 31, 65A (1998).
Klagsbrun, M. The fibroblast growth factor family: Structural and biological properties. Prog. Growth Factor Res. 1, 207–235 (1989).
Unger, E.F. et al. Basic fibroblast growth factor enhances myocardial collateral flow in canine model. Am. J. Physiol. 266, H1588–1595 (1994).
Lazarous, D.F. et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 91, 145–153(1995).
Lazarous, D.F. et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 94, 1074–1082 (1996).
Mazue, G. et al. The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol. Pathol. 21, 490–501 (1993).
Schumacher, B., Pecher, P., Von Specht, B.U. & Induction of neoan-giogenesis in ischemic myocardium by human growth factors. Circulation 97, 645–650(1998).
Suri, C., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171–1180 (1996).
Giordano, F.J. et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2, 534–539 (1996).
Muhlhauser, J. et al. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient recombinant adenovirus vectors. Gene Ther. 3, 145–153(1996).
Baumgartner, I. et al. Constitutive expression of phVEGFl 65 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97, 1114–1123 (1998).
Campbell, A.I.M., Monge, J.C., Latter, M.A., Kuliszewski, M.A. & Stewart, D.J. Direct DNA injection of vascular endothelial growth factor induces angiogenesis in non-ischemic myocardium. J. Am. Coll. Card. 31, 25A (1998).
Isner, J.M. et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348, 370–374 (1996).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, J., Feldman, A. Gene therapy for therapeutic myocardial angiogenesis: A promising synthesis of two emerging technologies. Nat Med 4, 739–742 (1998). https://doi.org/10.1038/nm0698-739
Issue Date:
DOI: https://doi.org/10.1038/nm0698-739
This article is cited by
-
Cardiovascular gene therapy: current status and therapeutic potential
British Journal of Pharmacology (2007)
-
Radionuclide reporter gene imaging for cardiac gene therapy
European Journal of Nuclear Medicine and Molecular Imaging (2007)
-
Polymer based cardiovascular gene therapy
Biotechnology and Bioprocess Engineering (2007)
-
Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer
Gene Therapy (2003)
-
Vectors for gene therapy of cardiovascular disease
Current Cardiology Reports (2000)